Robert Dreicer, MD

Articles by Robert Dreicer, MD

Dr. Dreicer on New Target Agents Improving Treatment

ByRobert Dreicer, MD

April 11th 2011

Prostate Cancer Advances From the Past 10 Years

ByRobert Dreicer, MD

April 6th 2011

Dr. Dreicer Talks About the State of the Healthcare System

ByRobert Dreicer, MD

April 5th 2011

Dr. Dreicer Remarks on Healthcare Reform

ByRobert Dreicer, MD

April 4th 2011

Healthcare Reform

Dr. Dreicer on Disparities in the Healthcare System

ByRobert Dreicer, MD

April 4th 2011

Disparities in the Healthcare System

Dr. Dreicer on the Need to Diagnose and Treat Efficiently

ByRobert Dreicer, MD

March 31st 2011

Dr. Dreicer on Newer Prostate Therapy Survival Benefits

ByRobert Dreicer, MD

March 30th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival

Dr. Dreicer on Prostate Cancer Combination Therapy

ByRobert Dreicer, MD

March 29th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, discusses the various treatments that prostate cancer patients may receive in combination.

Trending on OncLive

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC

Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments

Sonrotoclax Approval Generates New Options and Possibilities for R/R MCL

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC